N6-methyladenosine-dependent signalling in cancer progression and insights into cancer therapies

Fenghua Tan(Central South University), Can Guo(Ministry of Agriculture), Mengyao Zhao(China Agricultural University), Bo Xiang(Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital), Fang Xiong(Nanjing Maternity and Child Health Care Hospital), Zhaoyang Zeng(Shenzhen Academy of Robotics), Ming Zhou(Zhejiang Chinese Medical University), Guiyuan Li(Xuzhou Medical College), Yong Li(Baylor College of Medicine), Xiaoling Li(Southwest University), Shanshan Zhang(Nanchang University), Yumin Wang(Central South University), Wei Xiong(Central South University), Lei Shi(Sun Yat-sen University), Fuyan Wang(Central South University), Xiayu Li(Central South University), Yi He(Tianjin University of Technology), Zhaojian Gong(Central South University)
Journal of Experimental & Clinical Cancer Research
April 29, 2021
10.1186/s13046-021-01952-4
Cited by 80

Related Papers

Circular RNAs function as ceRNAs to regulate and control human cancer progression
|Molecular Cancer|2018|1.1k
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|677
Effects of environmental pollutants on gut microbiota
|Environmental Pollution|2017|662
Regulatory mechanisms of PD-1/PD-L1 in cancers
|Molecular Cancer|2024|619